Category Pharmaceuticals

Monopolies on New Medicines & Trade with the U.S.

Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.

Pharmacare: Improving Access to Expensive Drugs

Marc-André Gagnon dispels misconceptions about the benefits of private health insurance plans and argues in favour of a universal model for pharmacare.

Beware: Direct-to-Consumer Pharmaceutical Ads

Andrea Frydl cautions Canadians about the harms of direct-to-consumer advertising for pharmaceuticals and offers advice for health care providers and policy makers.

Clean Needle Pilot Programs at 2 Federal Prisons

Chelsea Cox comments on the introduction of two clean needle exchange pilot programs in Canadian prisons.

Responding to the Opioid Epidemic

Matthew Herder considers possible regulatory responses to the opioid epidemic that aim to recover health care costs, compensate survivors, or prosecute pharmaceutical companies.

Transgender Women, Breastfeeding and Drug Regimens

Martha Paynter reasons that the parent-infant benefits of breastfeeding/chestfeeding outweigh concerns about drug regimens that facilitate transgender women’s lactation.

A Step Forward for Self-administered MAiD in Canada

Jocelyn Downie and Stefanie Green argue that secobarbital, a self-administered medication for medical assistance in dying, will increase patient access and autonomy.